期刊文献+

胺碘酮转复阵发心房颤动的疗效观察

下载PDF
导出
摘要 目的对比胺碘酮和毛花甙C治疗阵发心房颤动(房颤)的疗法。方法阵发性房颤,随机分为胺碘酮组(30例)和毛花甙C组(29例),胺碘酮组静脉注射胺碘酮150~300mg,随后以1mg/min的滴速予以静滴;毛花甙C组静脉注射0.4—0.8mg,观察其复律情况、心室率的变化、QT间期及药物副作用。结果毛花甙C组阵发房颤29例,复律成功14例;胺碘酮组30例,复律成功23例,两组未复律者心室率均有明显控制,QT间期及副作用差异无显著性意义。胺碘酮组复律平均时间为5.1h,毛花甙C组复律平均时间为3.5h。结论阵发性房颤的复律疗效胺碘酮高于毛花甙C。
出处 《中国血液流变学杂志》 CAS 2009年第4期553-553,556,共2页 Chinese Journal of Hemorheology
  • 相关文献

参考文献2

二级参考文献25

  • 1Thomas D, Kathofer S, Zhang W, et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol,2003,140:996-1002.
  • 2Shingawa K, Shiroshita-Takeshita A, Schram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium:insights into the mechanism of the superior efficacy of amiodarone. Circulation,2003,107:1440-1446.
  • 3Haikerwal D, Esler MD, Dart AM. Acute electrophysiologic effects of intravenous amiodarone are independent of a sympatholytic action in humans. J Cardiovasc Pharmacol, 2003,41:760-765.
  • 4Letelier LM, Udol K, Ena J, et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a metaanalysis. Arch Intern Med,2003 ,163 :777-785.
  • 5Khan IA, Mehta NJ, Gowda RM. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol, 2003,89: 239-248.
  • 6Bernard EO, Schmid ER, SchmidlinD, et al. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Crit Care Med,2003,31:1031-1034.
  • 7Naccarelli GV,Wolbretted L,Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation:comparative efficacy and results of trials. Am J Cardiol,2003,91 (Suppl): 15D-26D.
  • 8Levy S. Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint. Cardiovascdrugs Ther, 1994,8: 769 -771.
  • 9Fuster V,Ryde'n LE,Asinger RW,et al,for the Committee to develop Guidelines for the Management of Patients with Atrial Fibrillation Investigators. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation: executive Summary. Circulation ,2001,104:2118-2150.
  • 10Roy D,Talajic M,Dorian P,et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med ,2000,342:913-920.

共引文献416

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部